NovoCure Ltd
NVCR- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001645113
No open-market purchases or sales by NovoCure Ltd insiders were filed in the last 90 days; 218 institutions reported holding it in 13F filings for Q2 2026, worth $1.57B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by NovoCure Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for NovoCure Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Puri Michal Nath | Chief Human Resources Officer | 203,227 | Jul 1, 2026 | 4 |
| Leonard Frank X | Chief Executive Officer | 461,425 | Jul 1, 2026 | 5 |
| Ben Arye Barak | General Counsel | 243,752 | Jul 1, 2026 | 3 |
| Danziger Asaf | Director | 416,742 | Jul 1, 2026 | 1 |
| Hilleman Jeryl L | Director | 25,471 | Jun 5, 2026 | 2 |
| Leung Gabriel | Director | 101,109 | Jun 5, 2026 | 2 |
| Hung David | Director | 32,075 | Jun 5, 2026 | 2 |
| Vernon W Anthony | Director | 209,267 | Jun 5, 2026 | 3 |
| Scannell Timothy J | Director | 25,898 | Jun 5, 2026 | 2 |
| Madden Martin J. | Director | 30,284 | Jun 5, 2026 | 1 |
| Ocean Allyson J | Director | 22,934 | Jun 5, 2026 | 2 |
| Stafford Kristin | Director | 22,934 | Jun 5, 2026 | 2 |
| Doyle William F | Executive Chairman | 328,397 | Mar 5, 2026 | 1 |
| Weinberg Uri | Chf Medical and Innovation Ofr | 267,190 | Mar 5, 2026 | 2 |
| Cordova Ashley | Former Chief Executive Officer | 422,570 | Mar 5, 2026 | 2 |
| Leupin Nicolas | Former Chief Medical Officer | 102,979 | Mar 5, 2026 | 2 |
| Paravasthu Mukund | Chief Operating Officer | 72,832 | Mar 5, 2026 | 4 |
| Brackmann Christoph | Chief Financial Officer | 182,842 | Mar 5, 2026 | 2 |
| Groenhuysen Wilhelmus CM | Chief Operating Officer | 252,290 | Aug 6, 2024 | 0 |
| Giladi Moshe | Chief Science Officer | 69,771 | Feb 29, 2024 | 0 |
| Shah Pritesh | Chief Growth Officer | 124,511 | Nov 8, 2023 | 0 |
| Burke William Patrick | Chief Human Resources Officer | 66,447 | Jul 6, 2023 | 0 |
| Benaim Ely | Chief Medical Officer | 28,770 | Jan 10, 2023 | 0 |
| Longsworth Todd Christopher | General Counsel | 62,462 | Mar 9, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Hung DavidDirector | SSale | −999 | $17.30 | −$17.3K | −7.6%12.2K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Vernon W AnthonyDirector | SSale | −999 | $17.35 | −$17.3K | −0.6%167.9K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Ocean Allyson JDirector | SSale | −999 | $17.29 | −$17.3K | −24.6%3.05K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Hilleman Jeryl LDirector | SSale | −999 | $17.26 | −$17.2K | −15.2%5.59K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Scannell Timothy JDirector | SSale | −999 | $17.32 | −$17.3K | −14.2%6.02K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Madden Martin J.Director | SSale | −999 | $17.19 | −$17.2K | −5.1%18.7K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Leung GabrielDirector | SSale | −999 | $17.31 | −$17.3K | −1.2%81.2K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Stafford KristinDirector | SSale | −999 | $17.28 | −$17.3K | −24.6%3.05K after | |
| Jul 30, 2025 (view filing) | Jul 29 | 1 day | Brackmann ChristophChief Financial Officer | PPurchase | +20.0K | $11.59 | +$231.8K | +16.5%141.2K after | 3 lots |
| Sep 8, 2025 (view filing) | Sep 5 | 3 days | Cordova AshleyChief Executive Officer | PPurchase | +81.5K | $12.22 | +$996.5K | +22.9%437.6K after | |
| Mar 3, 2026 (view filing) | Feb 27-Mar 2 | 4 days | Weinberg UriChf Medical and Innovation Ofr | SSale | −10.7K | $13.68 | −$146.9K | −4.6%223.5K after | 2 lots |
| Mar 3, 2026 (view filing) | Feb 27-Mar 2 | 4 days | Leonard Frank XChief Executive Officer | SSale | −17.0K | $13.59 | −$230.5K | −4.6%349.4K after | 2 lots |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Puri Michal NathChief Human Resources Officer | SSale | −1.44K | $13.66 | −$19.7K | −0.9%162.3K after | |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Leupin NicolasFormer Chief Medical Officer | SSale | −1.03K | $13.66 | −$14.1K | −1.0%104.1K after | |
| Mar 3, 2026 (view filing) | Feb 27-Mar 2 | 4 days | Paravasthu MukundChief Operating Officer | SSale | −1.96K | $13.62 | −$26.7K | −2.5%76.3K after | 2 lots |
| Mar 5, 2026 (view filing) | Mar 3 | 2 days | Doyle William FExecutive Chairman | SSale | −71.9K | $12.98 | −$933.1K | −18.0%328.4K after | 2 lots |
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Weinberg UriChf Medical and Innovation Ofr | SSale | −6.41K | $13.31 | −$85.3K | −2.3%267.2K after | |
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Leonard Frank XChief Executive Officer | SSale | −5.61K | $13.31 | −$74.6K | −1.1%493.8K after | |
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Puri Michal NathChief Human Resources Officer | SSale | −1.10K | $13.31 | −$14.6K | −0.5%201.3K after | |
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Leupin NicolasFormer Chief Medical Officer | SSale | −1.10K | $13.31 | −$14.6K | −1.1%103.0K after | |
| Mar 5, 2026 (view filing) | Mar 4-5 | 1 day | Paravasthu MukundChief Operating Officer | SSale | −48.6K | $13.72 | −$667.1K | −40.0%72.8K after | 2 lots |
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Brackmann ChristophChief Financial Officer | SSale | −6.41K | $13.31 | −$85.3K | −3.4%182.8K after | |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Hilleman Jeryl LDirector | SSale | −2.94K | $15.77 | −$46.4K | −17.5%13.9K after | |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Leung GabrielDirector | SSale | −2.94K | $15.77 | −$46.4K | −3.2%89.5K after | |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Hung DavidDirector | SSale | −2.94K | $15.77 | −$46.4K | −12.6%20.5K after | |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Vernon W AnthonyDirector | SSale | −2.94K | $15.77 | −$46.4K | −1.5%197.7K after | |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Scannell Timothy JDirector | SSale | −2.94K | $15.77 | −$46.4K | −17.1%14.3K after | |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Ocean Allyson JDirector | SSale | −2.94K | $15.77 | −$46.4K | −20.6%11.3K after | |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Stafford KristinDirector | SSale | −2.94K | $15.77 | −$46.4K | −20.6%11.3K after | |
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Leonard Frank XChief Executive Officer | SSale | −34.3K | $17.93 | −$614.5K | −6.9%459.5K after |